Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Not Confirmed
Not Confirmed
28 October-01 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
28-30 October, 2024
SupplySide West 2024SupplySide West 2024
Industry Trade Show
Not Confirmed
28 October-01 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
22 May 2024
// PRESS RELEASE
https://xbrane.com/en/mfn_news/xbrane-successfully-scales-up-xdivane-biosimilar-candidate-to-opdivo-and-run-an-active-partnering-process/
10 May 2024
// ENDPTS
https://endpts.com/iteos-to-raise-120m-xbrane-and-stada-to-out-license-lucentis-biosimilar/
13 Apr 2024
// PRESS RELEASE
https://xbrane.com/en/mfn_news/xbrane-provides-regulatory-update-on-fda-review-of-its-ranibizumab-biosimilar-candidate/
11 Nov 2022
// PHARMATIMES
https://www.pharmatimes.com/news/stada_and_xbrane_gain_eu_approval_for_biosimilar_ximluci_1480676
16 Sep 2022
// STADA
https://www.stada.com/blog/posts/2022/september/stada-and-xbrane-welcome-ema-positive-opinion-for-ranibizumab-biosimilar-candidate-ximluci
19 Feb 2022
// CENTERFORBIOSIMILARS
https://www.centerforbiosimilars.com/view/biosimilar-business-news-roundup-russia-launches-omalizumab-remsima-sales-soar-xbrane-trial-results
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?